Close Asset Management LTD Eli Lilly & CO Transaction History

Close Asset Management LTD

$3.55 Billion
Q4 2024

A detailed history of Close Asset Management LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Close Asset Management LTD holds 41,380 shares of LLY stock, worth $37.3 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

41,380

Previous 41,380 -0.0%

Holding current value

$37.3 Million

Previous $36.6 Million 12.74%

% of portfolio

0.9%

Previous 1.13%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $3.2 Million - $3.98 Million	4,144 Added 11.13%	41,380 $36.6 Million
Q2 2024 Aug 07, 2024	BUY	$724.87 - $909.04 $9.39 Million - $11.8 Million	12,958 Added 53.37%	37,236 $33.7 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $3.59 Million - $4.8 Million	6,054 Added 33.22%	24,278 $18.9 Million
Q4 2023 Feb 08, 2024	BUY	$525.19 - $619.13 $6.68 Million - $7.88 Million	12,722 Added 231.23%	18,224 $10.6 Million
Q3 2023 Oct 11, 2023	BUY	$434.7 - $599.3 $477,735 - $658,630	1,099 Added 24.96%	5,502 $2.96 Million
Q2 2023 Jul 26, 2023	BUY	$350.74 - $468.98 $560,131 - $748,961	1,597 Added 56.91%	4,403 $2.06 Million
Q1 2023 Apr 19, 2023	BUY	$310.63 - $364.82 $114,311 - $134,253	368 Added 15.09%	2,806 $963,000
Q4 2022 Jan 27, 2023	BUY	$321.55 - $374.67 $1,286 - $1,498	4 Added 0.16%	2,438 $892,000
Q3 2022 Oct 26, 2022	SELL	$296.48 - $337.87 $38,542 - $43,923	-130 Reduced 5.07%	2,434 $788,000
Q2 2022 Jul 29, 2022	BUY	$278.73 - $327.27 $143,545 - $168,544	515 Added 25.13%	2,564 $832,000
Q4 2021 Jan 27, 2022	SELL	$224.85 - $279.04 $42,721 - $53,017	-190 Reduced 8.49%	2,049 $566,000
Q3 2021 Nov 04, 2021	SELL	$221.6 - $272.71 $22,824 - $28,089	-103 Reduced 4.4%	2,239 $517,000
Q2 2021 Jul 27, 2021	SELL	$180.55 - $233.54 $27,263 - $35,264	-151 Reduced 6.06%	2,342 $537,000
Q2 2020 Jul 28, 2020	SELL	$136.42 - $164.18 $16,233 - $19,537	-119 Reduced 4.56%	2,493 $409,000
Q1 2020 May 05, 2020	SELL	$119.05 - $147.35 $17,857 - $22,102	-150 Reduced 5.43%	2,612 $362,000
Q4 2019 Jan 22, 2020	BUY	$106.92 - $132.43 $5,559 - $6,886	52 Added 1.92%	2,762 $363,000
Q2 2019 Aug 01, 2019	BUY	$110.79 - $129.32 $85,086 - $99,317	768 Added 39.55%	2,710 $300,000
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $2.5 Million - $2.95 Million	-22,489 Reduced 92.05%	1,942 $252,000
Q4 2018 Jan 28, 2019	BUY	$105.9 - $118.64 $2.38 Million - $2.67 Million	22,489 Added 1158.03%	24,431 $1.1 Million
Q3 2018 Nov 09, 2018	BUY	$85.86 - $107.31 $119,517 - $149,375	1,392 Added 253.09%	1,942 $208,000
Q1 2018 May 11, 2018	SELL	$74.21 - $87.6 $1,855 - $2,190	-25 Reduced 4.35%	550 $42,000
Q2 2017 Nov 14, 2017	SELL	N/A	-140 Reduced 19.58%	575 $0
Q1 2017 Nov 14, 2017	SELL	N/A	-297 Reduced 29.35%	715 $60,000
Q4 2016 Nov 14, 2017	BUY	N/A	1,012	1,012 $74,000

Others Institutions Holding LLY

# of Institutions

4,270

Shares Held

757M

Call Options Held

10.2M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $857B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Close Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Close Asset Management LTD with notifications on news.

Account

Close Asset Management LTD Eli Lilly & CO Transaction History